Notizie Newsletter
ASCO Announces 2019-20 Health Policy Leadership Development Program Fellows
May 29, 2019 - The American Society of Clinical Oncology (ASCO) today announced the Health Policy Leadership Development Program Fellows for the 2019-2020 class. Wendy Allen-Rhoades, MD, of Baylor College of Medicine, and Laura LaNiel Tenner, MD, MPH, of The Mays Cancer ...Leggi tutto
FDA Approves Lenalidomide/Rituximab for Indolent Non-Hodgkin Lymphoma
May 28, 2019 - The FDA has approved the R2 regimen of lenalidomide plus rituximab for use in patients with previously treated follicular lymphoma and marginal zone lymphoma (MZL). The approval was primarily based on the phase III AUGMENT trial, in which the R2 regimen reduced ...Leggi tutto
FDA Grants Fast Track Designation to ARV-110 for mCRPC
May 29, 2019 - The FDA has granted a fast track designation to ARV-110, a protein degrader, for use as a treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who have disease progression following ≥2 systemic therapies. The orally bioavailable ...Leggi tutto